HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

and clinical vaccination trials have demonstrated induction of tumor-specific immunity, the function of immunoglobulin-specific CD8 + cytotoxic T lymphocytes in tumor rejection remains elusive.

To date no treatment exists for lymphopenia, a depletion of critical lymphocytes responsible ... infections but also deprives the body’s immune system to fight residual or recurrent cancer ...

Nektar Therapeutics' REZPEG shows progress in treating atopic dermatitis & alopecia areata. Click here to find out why I rate ...

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...

A Montreal researcher recently received a major $1.2 million grant from the Canadian Institutes of Health Research to better ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

The Leaving Cert biology paper (higher level) has been well-received by teacher and students alike, with praise for the ...

(12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) <li /> EO ...

Primary sclerosing cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition ...

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...